Treatment of cancer associated thrombosis. 2019 update of the French guidelines

被引：10
作者：
Mahe, I [1 ]
Meyer, G. [2 ]
Girard, P. [3 ]
Bertoletti, L. [4 ]
Laporte, S. [5 ]
Couturaud, F. [6 ]
Mismetti, P. [4 ]
Sanchez, O. [7 ]
机构：
[1] Univ Paris, Hop Louis Mourier, Assistance Publ Hop Paris, Serv Med Interne,Colombes,INSERM,UMR S1140,F CRIN, St Etienne, France
[2] Univ Paris, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris,F CRIN INNOVTE, Serv Pneumol & Soins Intensifs,INSERM,UMRS 970,CI, St Etienne, France
[3] Inst Mutualiste Montsouris, Inst Thorax Curie Montsouris, F CRIN INNOVTE, St Etienne, France
[4] Univ Jean Monnet, Serv Med Vasc & Therapeut, CHU St Etienne,F CRIN INNOVTE, INSERM,UMR1059,Equipe Dysfonct Vasc & Hemostase,C, St Etienne, France
[5] Univ Lyon, SAINBOIS U1059 Equipe DVH, Univ Jean Monnet,Hop Nord,F CRIN INNOVTE, INSERM,Unite Rech Clin,Innovat,Pharmacol,CHU St E, St Etienne, France
[6] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Dept Med Interne & Pneumol, F CRIN INNOVTE,EA3878,GETBO,CIC INSERM1412, St Etienne, France
[7] Univ Paris, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, INSERM,UMRS 1140,Serv Pneumol & Soins Intensifs,F, St Etienne, France
来源：
REVUE DES MALADIES RESPIRATOIRES | 2021年 / 38卷 / 04期
关键词：
MOLECULAR-WEIGHT HEPARIN; RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; SECONDARY PREVENTION; PULMONARY-EMBOLISM; DOSE-ESCALATION; ACTIVE CANCER; WARFARIN; DALTEPARIN; MANAGEMENT;
D O I：
10.1016/j.rmr.2021.03.001
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：427 / 437
页数：11
相关论文
共 40 条
[1]   Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer [J].
Agnelli, Giancarlo ;
Becattini, Cecilia ;
Meyer, Guy ;
Munoz, Andres ;
Huisman, Menno, V ;
Connors, Jean M. ;
Cohen, Alexander ;
Bauersachs, Rupert ;
Brenner, Benjamin ;
Torbicki, Adam ;
Sueiro, Maria R. ;
Lambert, Catherine ;
Gussoni, Gualberto ;
Campanini, Mauro ;
Fontanella, Andrea ;
Vescovo, Giorgio ;
Verso, Melina .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17) :1599-1607
[2]   Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH [J].
Carrier, M. ;
Khorana, A. A. ;
Zwicker, J. I. ;
Noble, S. ;
Lee, A. Y. Y. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (09) :1760-1765
[3]   Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients [J].
Carrier, M. ;
Le Gal, G. ;
Cho, R. ;
Tierney, S. ;
Rodger, M. ;
Lee, A. Y. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) :760-765
[4]   Epidemiology of first and recurrent venous thromboembolism in patients with active cancer A population-based cohort study [J].
Cohen, Alexander T. ;
Katholing, Anja ;
Rietbrock, Stephan ;
Bamber, Luke ;
Martinez, Carlos .
THROMBOSIS AND HAEMOSTASIS, 2017, 117 (01) :57-65
[5]   Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: a case-control study [J].
D'Izarn, M. Sahut ;
Prim, A. Caumont ;
Planquette, B. ;
Revel, M. P. ;
Avillach, P. ;
Chatellier, G. ;
Sanchez, O. ;
Meyer, G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) :2032-2038
[6]   A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2) [J].
Davies, G. A. ;
Lazo-Langner, A. ;
Gandara, E. ;
Rodger, M. ;
Tagalakis, V. ;
Louzada, M. ;
Corpuz, R. ;
Kovacs, M. J. .
THROMBOSIS RESEARCH, 2018, 162 :88-92
[7]   International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer [J].
Debourdeau, P. ;
Farge, D. ;
Beckers, M. ;
Baglin, C. ;
Bauersachs, R. M. ;
Brenner, B. ;
Brilhante, D. ;
Falanga, A. ;
Gerotzafias, G. T. ;
Haim, N. ;
Kakkar, A. K. ;
Khorana, A. A. ;
Lecumberri, R. ;
Mandala, M. ;
Marty, M. ;
Monreal, M. ;
Mousa, S. A. ;
Noble, S. ;
Pabinger, I. ;
Prandoni, P. ;
Prins, M. H. ;
Qari, M. H. ;
Streiff, M. B. ;
Syrigos, K. ;
Buller, H. R. ;
Bounameaux, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) :71-80
[8]   Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period [J].
Deitcher, Steven R. ;
Kessler, Craig M. ;
Merli, Geno ;
Rigas, James R. ;
Lyons, Roger M. ;
Fareed, Jawed .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (04) :389-396
[9]   Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients [J].
Delluc, Aurelien ;
Le Gal, Gregoire ;
Scarvelis, Dimitrios ;
Carrier, Marc .
THROMBOSIS RESEARCH, 2015, 135 (02) :298-302
[10]   Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study [J].
Di Nisio, Marcello ;
van Es, Nick ;
Carrier, Marc ;
Wang, Tzu-Fei ;
Garcia, David ;
Segers, Annelise ;
Weitz, Jeffrey ;
Buller, Harry ;
Raskob, Gary .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (11) :1866-1874
1234